Matthew K Abramowitz
Overview
Explore the profile of Matthew K Abramowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fisher M, Hanna D, Fazzari M, Felsen U, Wyatt C, Abramowitz M, et al.
J Acquir Immune Defic Syndr
. 2024 Dec;
98(5):501-505.
PMID: 39729640
Background: The Veterans Aging Cohort Study (VACS) Index is a summary measure of routinely obtained clinical variables that predicts numerous health outcomes. Because there are currently no tools to predict...
2.
Fisher M, Fazzari M, Felsen U, Hanna D, Tappan N, Wyatt C, et al.
Kidney Int
. 2023 Aug;
104(5):1008-1017.
PMID: 37598853
In the modern era, it is unknown if people that are virally suppressed with HIV (PWH) are at increased risk for acute kidney injury (AKI) compared to people without HIV...
3.
Kilduff S, Hayde N, Viswanathan S, Reidy K, Abramowitz M
Pediatr Nephrol
. 2023 Jul;
38(12):4165-4173.
PMID: 37422606
Background: Metabolic acidosis is a risk factor for faster kidney function decline in chronic kidney disease (CKD) and in adult kidney transplant recipients (KTRs). We hypothesized that metabolic acidosis would...
4.
Xie Y, Mossavar-Rahmani Y, Chen Y, Abramowitz M, Chen W
J Ren Nutr
. 2023 Jun;
33(5):657-665.
PMID: 37302720
Objectives: Arterial calcification contributes to cardiovascular mortality. Based on a recent animal study, we hypothesized that higher dietary potassium intake was associated with less abdominal aortic calcification (AAC) and lower...
5.
6.
Lambert D, Kane J, Slaton A, Abramowitz M
Kidney360
. 2022 Dec;
3(11):1842-1851.
PMID: 36514392
Background: Obesity is a recently identified risk factor for metabolic acidosis and anion gap elevations in the absence of CKD. Metabolic acidosis is a treatable condition with substantial adverse effects...
7.
Cohen B, Munugoti S, Kotwani S, Randhawa L, Dalezman S, Elters A, et al.
Kidney360
. 2022 Oct;
3(9):1545-1555.
PMID: 36245649
Background: Physical inactivity is common in patients receiving hemodialysis, but activity patterns throughout the day and in relation to dialysis are largely unknown. This knowledge gap can be addressed by...
8.
Ho J, Abramowitz M
Adv Chronic Kidney Dis
. 2022 Sep;
29(4):395-405.
PMID: 36175077
Metabolic acidosis is common in people with chronic kidney disease and can contribute to functional decline, morbidity, and mortality. One avenue through which metabolic acidosis can result in these adverse...
9.
Ho J, Verghese J, Abramowitz M
Sci Rep
. 2022 Jun;
12(1):9171.
PMID: 35654910
Metabolic acidosis is associated with impaired physical function in patients with chronic kidney disease (CKD) and older adults. However, whether acidosis is associated with gait abnormalities has received little attention....
10.
Lambert D, Abramowitz M
Kidney360
. 2022 Apr;
2(11):1706-1715.
PMID: 35372994
Background: Obesity is associated with low serum bicarbonate, an indicator of metabolic acidosis and a CKD risk factor. To further characterize acid-base disturbance and subclinical metabolic acidosis in this population,...